bioMérieux VIDAS D-Dimer Exclusion II

Nazione: Singapore

Lingua: inglese

Fonte: HSA (Health Sciences Authority)

Commercializzato da:

BIOMERIEUX SINGAPORE PTE. LTD.

Classe:

Class B IVD

Prodotto da:

BIOMERIEUX S.A.

Area terapeutica:

Immunology

Indicazioni terapeutiche:

VIDAS® D-Dimer Exclusion II™ is an automated quantitative test for use on the instruments of the VIDAS® family for the immunoenzymatic determination of fibrin degradation products (FbDP) in human plasma (sodium citrate) using the ELFA technique (Enzyme Linked Fluorescent Assay). VIDAS® D-Dimer Exclusion II™ is indicated for use in conjunction with a clinical pretest probability assessment model to exclude deep vein thrombosis (DVT) and pulmonary embolism (PE) disease in outpatients suspected of DVT or PE. VIDAS® D-Dimer Exclusion II™ is indicated for use in the HERDOO2 clinical decision rule (CDR) to assess the risk of recurrence of venous thromboembolism (VTE) in women with a first unprovoked VTE. Risk stratification by this CDR is an aid to guide the duration of oral anticoagulant therapy.

Dettagli prodotto:

Models: VIDAS® D-Dimer Exclusion II™ - 30455-02

Data dell'autorizzazione:

2018-11-13